Role of chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 2, 2011, Pages 95-101

  Al Ghamdi, Abdullah ^a,b   Jiman Fatani, Asif Ahmed ^a,b   El Banna, Hassan ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Atherosclerosis; Coronary artery disease; Cytomegalovirus; Epstein Barr virus; Herpes simplex virus; Peripheral artery disease

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CREATINE KINASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHLAMYDIAL PNEUMONIA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; MALE; PHYSICAL EXAMINATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; C-REACTIVE PROTEIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; LIPIDS; MALE; MIDDLE AGED;

EID: 79953867838     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Adiloglu AK, Can R, Kinay O and Aridogan BC (2005). Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels. Acta Cardiol., 60(6): 599-604. (Pubitemid 41784637)
2. Ayada K, Yokota K, Kobayashi K, Shoenfeld Y, Matsuura E and Oguma K (2009). Chronic infections and atherosclerosis. Clin. Rev. Allergy Immunol., 37(1): 44-48.
3. Corrado E and Novo S (2005). Role of inflammation and infection in vascular disease. Acta Chir. Belg., 105(6): 567-579. (Pubitemid 43080966)
4. Eckardstein AV (2004). Is there a need for novel cardiovascular risk factors? Nephrol. Dial. Transplant., 19(4): 761-765.
5. Eryol NK, Kilic H, Gul A, Ozdogru I, Inanc T, Dogan A, Topsakal R and Basar E (2005). Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease? Int. Heart J., 46(2): 205-209.
6. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, Hafner G, Prellwitz W, Schlumberger W and Meyer J (2002). Impact of infectious burden on progression of carotid atherosclerosis. Stroke, 33(11): 2581-2586. (Pubitemid 35266427)
7. Franceschi F, Navarese EP, Mollo R, Giupponi B, De Marco G, Merra G, Gasbarrini G, Silveri NG (2009). Helicobacter pylori and atherosclerosis. A review of the literature. Recenti. Prog. Med., 100(2): 91-96.
8. Gen R, Demir M, Ataseven H (2010). Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med. J., 103(3): 190-196.
9. Goyal P, Kalek SC, Chaudhry R, Chauhan S and Shah N (2007). Association of common chronic infections with coronary artery disease in patients without any conventional risk factors. Indian J. Med. Res., 125(2): 12-36.
10. Greenland P, Knoll MD and Stamler J (2003). Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA, 290: 891-897. (Pubitemid 37430460)
11. Gurfinkel E, and Lernoud V (2006). The role of infection and immunity in atherosclerosis. Expert Rev. Cardiovasc. Ther., 4(1): 131-137.
12. Hedayat DK, Jebeli M, Mandegar MH, Bagheri J, Nabavi SA, Eghtesadi-Araghi P, Mohammadzadeh R, Darehzereshki A, Chitsaz S and Abbasi A (2009). The association between Chlamydia pneumoniae DNA in arherosclerotic plaque and major risk factors in patients undergoing coronary artery bypass grafting. Kardiol. Pol., 67(9): 981-966.
13. Jha HC, Srivastava P, Divya A, Prasad J and Mittal A (2009). Prevalence of Chlamydophila pneumoniae is higher in aorta and coronary artery than in carotid artery of coronary artery disease patients. APMIS. 117(12): 905-911.
14. Jia EZ, Zhao FJ, Hao B, Zhu TB, Wang LS, Chen B, Cao KJ, Huang J, Ma WZ, Yang ZJ and Zhang G (2009). Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis., 23(8): 59.
15. Kanbay M, Gur G, Yucel M, Yilmaz U and Muderrisoglu H (2005). Helicobacter pylori seroprevalence in patients with coronary artery disease. Dig. Dis. Sci., 50(11): 2071-2074. (Pubitemid 41504091)
16. Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D, Papavassiliou VG, Perrea D and Kostakis AG (2006). Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg., 31(5): 509-515.
17. Khairy P, Rinfret S, Tardif JC, Marchand R, Shapiro S, Brophy J and Dupuis J (2003). Absence of association between infectious agents and endothelial function in healthy young men. Circulation, 107(15): 1966-1971. (Pubitemid 36506068)
18. Kowalski M, Pawlik M, Konturek JW and Konturek SJ (2006). Helicobacter pylori infection in coronary artery disease. J. Physiol. Pharmacol., 57(Suppl 3): 101-111. (Pubitemid 44617514)
19. Kutluana U, Simsek I, Akarsu M, Kupelioglu A, Karasu S and Altekin E (2005). Is there a possible relation between atrophic gastritis and premature atherosclerosis?. Helicobacter, 10(6): 623-629. (Pubitemid 41668349)
20. Kwon TW, Kim do K, Ye JS, Lee WJ, Moon MS, Joo CH, Lee H and Kim YK (2004). Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas. J. Microbiol., 42(4): 299-304. (Pubitemid 40137894)
21. Latsios G, Saetta A, Michalopoulos NV, Agapitos E and Patsouris E (2004). Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction. Acta Cardiol., 59(6): 652-657. (Pubitemid 39619972)
22. Lentine KL, Parsonnet J, Taylor I, Wrone EM and Lafayette RA (2006). Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients. Clin. Exp. Nephrol., 10(1): 55-62.
23. Maia IL, Nicolau JC, Machado Mde N, Maia LN, Takakura IT, Rocha PR, Cordeiro JA and Ramires JA (2009). Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae in different forms of coronary disease. Arq. Bras. Cardiol., 92(6): 405-411.
24. Mayr M, Kiechl S, Willeit J, Wick G and Xu Q (2000). Infections, immunity, and atherosclerosis: Associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation, 102(8): 833-839.
25. Mostaza JM, Camino N, Gerique JG, Pena R, Baquero M and Lahoz C (2004). C-reactive protein levels and prevalence of chronic infections in subjects with hypoalphalipoproteinemia. Metabolism, 54(1): 33-37.
26. Mousa A, Al-Zaki A, Taha S and Bakhiet M (2009). Induction of interleukin-18 in atherosclerotic patients: a role for Chlamydia pneumoniae. Med. Princ. Pract., 18(2): 105-110.
27. Niccoli G, Franceschi F and Cosentino NF (2010). Coronary atherosclerotic burden in patients with infection by CagA-positive strains Giupponi B, De Marco G, Merra G, Conte M, Montone RA, Ferrante G, Bacà M, Gasbarrini A, Silveri NG, Crea of Helicobacter pylori. Coron. Artery Dis., 21(4): 217-221.
28. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M and Kambe M (2005). Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J. Am. Coll. Cardiol., 45(8): 1219-1222. (Pubitemid 40523140)
29. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kuhbacher T, Nikolaus S, Namsolleck P, Blaut M, Hampe J, Sahly H, Reinecke A, Haake N, Gunther R, Kruger D, Lins M, Herrmann G, Folsch UR, Simon R and Schreiber S (2006). Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation, 113(7): 929-937. (Pubitemid 43879467)
30. Pinar A, Oc M, Akyon Y, Farsak B, Kocyildirim E, Us D, Zorlutuna Y, Tokgozoglu L and Boke E (2004). [The presence of Chlamydophila pneumoniae, Helicobacter pylori and cytomegalovirus in human atherosclerosis detected by molecular and serological methods]. Mikrobiyol. Bul., 38(3): 213-22. [Article in Turkish]
31. Romano Carratelli C, Nuzzo I, Cozzolino D, Bentivoglio C, Paolillo R and Rizzo A (2006). Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases. Int. Immunopharmacol., 6(5): 48-53.
32. Rothenbacher D, Brenner H, Mertens T, Hoffmann MM, Hoffmeister A and Koenig W (2005). Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease. BMC Cardiovasc. Disord., 5(1): 10-13.
33. Saunders BD and Trapp RG 1994). Basic and clinical biostatistics. (Second edition, Appleton & Lange, Norwalk, Connecticut, pp-20-45.
34. Sawayama Y, Kikuchi K, Tatsukawa M, Hayashi S, Taira Y, Furusyo N and Hayashi J (2009). Association of Chlamydophila pneumoniae DNA in peripheral blood mononuclear cells and IgA antibody with atherosclerotic diseases. Fukuoka Igaku Zasshi., 100(9): 305-312.
35. Thomas B, Nader R and Pepys MB (2003). Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin. Chem., 49: 1258-1271.
36. Vahdat K, Jafari SM, Pazoki R and Nabipour I (2007). Concurrent increased high sensitivity C-reactive protein and chronic infections are associated with coronary artery disease: a population-based study. Indian J. Med. Sci., 61(3): 135-43. (Pubitemid 46393188)
37. Vercellotti GM (2001). Overview of infections and cardiovascular diseases. J. Allergy Clin. Immunol., 108(4 Suppl): S117-S120. (Pubitemid 32978008)
38. Wang SS, Tondella ML, Bajpai A, Mathew AG, Mehranpour P, Li W, Kacharava AG, Fields BS, Austin H and Zafari AM (2007). Circulating Chlamydia pneumoniae DNA and advanced coronary artery disease. Int. J. Cardiol., 118(2): 215-219. (Pubitemid 46601650)
39. Watt S, Aesch B, Lanotte P, Tranquart F and Quentin R (2003). Viral and bacterial DNA in carotid atherosclerotic lesions. Eur. J. Clin. Microbiol. Infect. Dis., 22(2): 99-105. (Pubitemid 36349971)
40. West SK, Kohlhepp SJ, Jin R, Gleaves CA, Stamm W and Gilbert DN (2009). Detection of circulating Chlamydophila pneumoniae in patients with coronary artery disease and healthy control subjects. Clin. Infect. Dis., 148(5): 560-567.
41. Zhu J, Davidson M, Leinonen M, Saikku P, Gaydos CA, Canos DA, Gutman KA, Howard BV and Epstein SE (2006). Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: The GOCADAN Study. Clin. Microbiol. Infect., 12(2): 118-22. (Pubitemid 43379338)